EBT-101 not checked

Excision BioTherapeutics

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
HIV-1-infection
Main trialPhase 1
“Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).”In the company’s words, NCT05143307 on ClinicalTrials.gov

Other drugs for HIV-1-infection

All 24 drugs for HIV-1-infection

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1Enrolling by invitation Jan 2037 Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
Phase 1Completed 14 Nov 2024 Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow EBT-101

Following is part of Solo: you see every change to EBT-101 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in